What cannabis investors should watch for in 2025
While 2024 brought its share of volatility, regulatory uncertainty and market pressures for the cannabis industry, this year…
News January 3
Latest In: FDA
Congress asks FDA for hemp-derived cannabinoid powers in spending bill
An influential Republican-controlled House of Representatives committee passed a spending bill on Wednesday that addresses the proliferation of…
News July 10
Hemp nonprofits call on key House committee to weigh in on FDA regulation
A group of nonprofit and supplement organizations sent a letter pleading for the House of Representatives' Energy and…
News February 5
Legal and retail gurus explain how Schedule 3 could impact marijuana sales
If marijuana is moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, that would expand…
News November 15
‘Biggest thing, ever’: Marijuana rescheduling recommendation hailed
The disclosure Wednesday that top Biden administration health officials this week officially recommended marijuana be reclassified from a…
News August 30
Opinion: Who will be responsible for cannabis if the FDA breaks up?
When it comes to reorganizing the FDA, cannabis is like an unwanted child in a divorce. No one…
News May 19
Charlotte’s Web, BAT subsidiary seek FDA approval for hemp drug
Colorado-based CBD and hemp company Charlotte's Web Holdings and a British American Tobacco subsidiary are teaming up to seek…
News April 6
FDA to face questions about CBD rules from key congressional committee
The U.S. House Oversight Committee plans to grill Food and Drug Administration Commissioner Robert Califf about why the…
News January 17
FDA dings American Shaman, four others for ‘illegally selling’ CBD
The U.S. Food and Drug Administration flagged five companies for “illegally selling” products containing cannabidiol, including national CBD…
News November 23Featured
Latest Sponsored
